Score Overview
See the full market ranking โ
Fulgent Genetics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 421M to $ 322M and net income went from $ 214M to -$ 60M. Revenue increased in 2 of those 5 years; net income in 2.
Across Fulgent Genetics Inc's full reported history, from 2016 to 2025, revenue grew from $ 18M to $ 322M and net income went from -$ 5M to -$ 60M. Revenue increased in 70% of the years measured; net income in 50%.
Fulgent Genetics Inc currently holds a 5-year HDB Score of 2.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 18.71 | โ |
1 Year2025-08-12 | $ 21.01 | -10.95% |
5 Years2021-08-12 | $ 99.10 | -81.12% |
All Time2016-09-29 | $ 9.18 | 103.81% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2016-09-29 |
|---|---|---|---|---|
| Price | $ 18.71 | $ 21.01 | $ 99.10 | $ 9.18 |
| Return | โ | -10.95% | -81.12% | 103.81% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 323M | -$ 84M | $ 257M |
| 2025 | $ 322M | -$ 60M | $ 336M |
| 2024 | $ 283M | -$ 42M | $ 258M |
| 2023 | $ 289M | -$ 167M | $ 424M |
| 2022 | $ 618M | $ 143M | $ 526M |
| 2021 | $ 992M | $ 104M | $ 450M |
| 2020 | $ 421M | $ 214M | $ 299M |
| 2019 | $ 32M | $ 366K | $ 28M |
| 2018 | $ 21M | -$ 4M | $ 37M |
| 2017 | $ 18M | -$ 2M | $ 41M |
| IPO2016 | $ 18M | -$ 5M | $ 46M |
Explore beyond FLGT
You're looking at Fulgent Genetics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
